Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Cancer. 2014 Nov 4;121(5):790–799. doi: 10.1002/cncr.29092

Table 2.

Treatment Concordance by Patient Characteristics

Characteristics Treatment
Discordant
Weighted %
ALL PATIENTS 813 12.4
Age at diagnosis (yrs) P <0.01
<40 35 7.96
40–49 120 7.56
50–64 243 10.45
65–69 83 11.34
70+ 332 20.50
Race/ethnicity P =0.11a
White 417 12.00
Black 264 14.18
Hispanic 48 13.04
Other race/ethnicity 61 15.86
Unknown 23 7.82
Insurance P <0.01
Private 316 11.52
Medicare w/ supplement 220 9.65
Medicaid/Medicare only/Dual 214 17.88
None/Uninsured/Unknown 63 15.51
Census-tract Povertyb P=0.04a
< 20% (ref) 575 11.93
20% + 235 14.30
Unknown 3 20.48
Urban Rural Residence P =0.02a
Urban 428 13.75
Urban Rural Mix 269 10.73
Rural 113 10.96
Unknown 3 21.92
Census-tract Educationc P =0.20a
High 450 11.91
Low 360 13.27
Unknown 3 20.48
State of Residence P <0.01
NC 95 10.28
GA 194 10.27
LA 143 11.23
KY 52 11.86
WI 76 15.62
MN 66 8.59
CA 187 17.88
Surgical facility CoC status P = 0.08a
Yes 362 11.15
No 316 13.12
Unknown 135 14.80
Clinical Tumor stage P <0.01
DCIS < 0.5 5 2.51
DCIS > 0.5 162 19.50
Stage I (N0, < 5cm) 369 11.16
Stage IIA (N0, <5cm) 162 14.54
Stage IIA (N1, < 5cm) 54 8.82
Stage IIB (N0, > 5cm) 33 28.45
Stage IIIA (N2, < 5cm) 7 5.57
Stage IIIA (N1, > 5cm) 16 10.95
Stage IIIA (N2, > 5cm) 5 18.58
Lymph node status P =0.26a
Negative 269 7.63
Positive 149 8.79
Undetermined 395 33.94
Comorbidity P <0.01a
No 284 10.18
Mild 326 11.86
Moderate/Severe 167 18.48
Unknown 36 32.34
Surgery P <0.01
Mastectomy 52 2.11
BCS 681 17.85
Lymph node dissection No P< 0.01 417 35.43
Yes 395 7.62
a

Ignores ‘Unknown’ or ‘Undetermined’ category

b

High poverty was defined as 20% or more of persons with income below the federal-defined poverty level.

c

Low education was defined as 25% or more of adults (aged 25 years and older) with less than a high school education.

d

Borderline ER or PR was grouped with the ER+ and/or PR+ group.